Thursday, January 05, 2017 8:42:21 AM
Assuming the company is still operating, of course.
The most obvious solution for the Whelans: scuttle the company by filing for bankruptcy protection, declare the loans in default, and transfer the patents to IBEX. Then IBEX can possibly sell the patents for a few million and laugh all the way to the bank.
That is the OBVIOUS solution. Judging from the History of Bioelectronics and the Education its shareholders have received about this company's propensity for lying and breaking SEC and FDA laws, I think it is also the most LIKELY outcome.
BIEL might get more $$$ for the patents if they wait for FDA clearance before cashing out on the patents. So it's a waiting game, IMO. Kind of interesting to watch, but also kind of sad.
BIEL might get very little $$$ for the patents, with or without FDA clearance. Prospective buyers who looks at the books and sees the failure of the ActiPatch in the UK might assume that the ActiPatch is going to also be a commercial failure in the US.
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM